Home Page
About SAEN
Articles and Reports
Contact Us
Events and Campaigns
Fact Sheets
Financial Information
How You Can Help
Make a Donation, Please!
Media Coverage
Newsletters
Petitions
Picture Archive
Press Releases
Resources and Links
Grass Roots Org. List

|
Stop Animal
Exploitation NOW!
S. A. E. N.
"Exposing the truth to wipe
out animal experimentation"

 Articles and
Reports
Alternatives to Animal Research and Testing
Alternatives to Ascites Production of Monoclonal Antibodies
by John McArdle, Ph.D.
Alternatives Research and Development Foundation
Eden Prairie, Minnesota
www.nal.usda.gov/awic/newsletters/v8n3/8n3mcard.htm
The Future Of MAb Production
If current trends continue, the use of animals to produce monoclonal
antibodies will eventually be replaced with in vitro alternatives.
Although still being refined, new recombinant biotechnology methods
based on phage display and combinatorial antibody libraries have the
potential to replace the use of animals and animal cells at all stages
of the antibody production process, by eliminating the need for the
initial immunization and subsequent formation and growth of the
hybridoma cells.
These entirely in vitro, high technology approaches mimic and, in
some cases, improve upon the natural immune system mechanisms. They
accomplished this by creating large libraries of all possible
antibodies, including those that would be difficult or impossible to
prepare using standard immunization and MAb hybridoma techniques. This
is particularly important for the production and use of human MAbs,
which are not readily produced using ascites, but are easily derived
from the use of recombinant techniques (3, 12, 25, 26).
At present these biotechnology approaches to antibody differentiation
and production are not equivalent to or less expensive than ascites or
in vitro hybridoma methods. They also require specialized knowledge and
skills but will become more competitive and eventually the system of
choice as the methodology is refined and developed into commercial kits
suitable for use in small to large-scale laboratory applications.
Go on to
Conclusion
Return to
Alternatives to Ascites Production
of Monoclonal Antibodies
Return to
Alternatives to Animal Research and Testing
Return to
Articles and Reports
Fair Use Notice: This document may contain
copyrighted material whose use has not been specifically authorized by
the copyright owners. We believe that this not-for-profit, educational
use on the Web constitutes a fair use of the copyrighted material (as
provided for in section 107 of the US Copyright Law). If you wish to use
this copyrighted material for purposes of your own that go beyond fair
use, you must obtain permission from the copyright owner
|